Study successfully achieved both primary endpoints Second positive Phase 3 demonstrating the safety and efficacy of IMVAMUNE and final study required for licen...

ITU leads United Nations dialogue on Artificial Intelligence The 2nd AI for Good Global Summit at ITU Headquarters in Geneva, 15-17 May 2018, will take action to ensu...

Fexinidazole would be first all-oral treatment* under investigation for both first and second stages of sleeping sickness, a fatal disease, endemic in Africa S...

New research published by the Journal of the Royal Society of Medicine exposes the extent of redactions in protocols for industry-sponsored randomised drug trials. Tr...

The study will evaluate safety and efficacy of the Colovac bypass device for ostomy-free anastomosis protection following colorectal surgery  SafeHeal, a leading inno...

Share in $1,000,000 (£720,000 GBP) for real and innovative solutions to problems faced by Idiopathic Pulmonary Fibrosis sufferers One of only two UK finalists – ...

Acquired intellectual property rights have potential application in a variety of clinical indications, including auto-immune disorders and neurodegenerative diseas...